title: Refractory primary central nervous system vasculitis of childhood: successful treatment with infliximab.
authors.forename: Michelle
authors.initials: M
authors.lastname: Batthish
authors.forename: Brenda
authors.initials: B
authors.lastname: Banwell
authors.forename: Suzanne
authors.initials: S
authors.lastname: Laughlin
authors.forename: William
authors.initials: W
authors.lastname: Halliday
authors.forename: Christine
authors.initials: C
authors.lastname: Peschken
authors.forename: Emile
authors.initials: E
authors.lastname: Paras
authors.forename: Susanne
authors.initials: S
authors.lastname: Benseler
mesh_terms: D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D002648:Child; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D000069285:Infliximab; D008279:Magnetic Resonance Imaging; D017211:Treatment Failure; D016896:Treatment Outcome; D020293:Vasculitis, Central Nervous System / Q000188:drug therapy* / Q000473:pathology*
chemical_list: D000305:Adrenal Cortex Hormones; D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D003520:Cyclophosphamide; D000069285:Infliximab